- CEO
- Hua Zhu
- Full Time Employees
- 16
- Sector
- Health technology
- Industry
- Biotechnology
- Address
- 122 Emerald Hill Singapore CE Singapore 229405
- IPO Date
- Dec 19, 2018
- Business
- Embracing Future Holdings Limited, incorporated in Singapore in 2009 and formerly known as Biolidics Limited until its renaming in June 2025, is a precision medicine medical technology and diversified investment holding company. The company develops and commercializes diagnostic solutions with a focus on cell enrichment systems used in cancer diagnostics, prognosis, treatment selection, and treatment monitoring. Its core products include the ClearCell® FX1 System, a fully automated in vitro diagnostic medical device that isolates and enriches cancer cells from blood samples. The company operates multiple business segments including cancer diagnostics, infectious diseases, laboratory services with regulatory approval for COVID-19 testing in Singapore, and corporate investment activities.
In recent years, Embracing Future Holdings has expanded its business scope to include technology-enabled lifestyle businesses such as multi-channel network (MCN) operations, live streaming social e-commerce platforms, and esports-related activities including game promotion and online event services. Further diversification includes strategic entry into green energy sectors focusing on renewable and sustainable energy sources like solar, wind, hydrogen, bioenergy, energy storage, and smart grid technologies, as well as artificial intelligence agent technologies leveraging generative AI, natural language processing, and machine learning for automation and digital transformation. Major recent developments include the acquisition of Shenzhen Xiaozhao Network Technology Co., Ltd in China to boost its esports marketing and services segment, establishment of subsidiaries Embracing Future E-Sports Pte. Ltd and Embracing Future MCN Pte. Ltd in 2024, and an active pursuit of strategic partnerships, joint ventures, and potential fundraising to strengthen and diversify its revenue base.
The company operates primarily in Singapore, Japan, and Hong Kong with a growing presence in the Chinese market through its acquisitions and new business ventures. It targets healthcare providers, research institutions, digital content consumers, esports audiences, and renewable energy markets. Embracing Future Holdings positions itself at the intersection of healthcare technology, digital media, esports, environmental sustainability, and AI, reflecting a strategic pivot towards high-growth emerging industries while maintaining its foundation in precision medical technology and laboratory services. Its headquarters remain at Novelty BizCentre, Singapore.